Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Phase 2
Completed
- Conditions
- Diarrhea Predominant Irritable Bowel Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2019-06-06
- Lead Sponsor
- Seldar Pharma, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT01896583
- Locations
- 🇺🇸
Elite Clinical Studies, Phoenix, Arizona, United States
🇺🇸Shahram Jacobs, M.D., Inc., Encino, California, United States
🇺🇸Grossmont Center for Clinical Research, La Mesa, California, United States
News
No news found